X
Xavier Calvet
Researcher at Autonomous University of Barcelona
Publications - 407
Citations - 13484
Xavier Calvet is an academic researcher from Autonomous University of Barcelona. The author has contributed to research in topics: Helicobacter pylori & Inflammatory bowel disease. The author has an hindex of 61, co-authored 365 publications receiving 12060 citations. Previous affiliations of Xavier Calvet include University of Barcelona & Carlos III Health Institute.
Papers
More filters
Journal ArticleDOI
Prevalence of antibodies to hepatitis c virus in spanish patients with hepatocellular carcinoma and hepatic cirrhosis
Jordi Bruix,Xavier Calvet,Josep Costa,Miquel Ventura,Miquel Bruguera,R. Castillo,J.M. Barrera,Guadalupe Ercilla,José María Sánchez-Tapias,Marti Vall,Concepció Brú,Joan Rodés +11 more
TL;DR: The results indicate that HCV infection may have a role in the pathogenesis of hepatocellular carcinoma, even in patients with chronic liver disease apparently related to other agents such as alcohol, and that this recently identified hepatitis virus may be found in a large proportion of patients with cryptogenic cirrhosis.
Journal ArticleDOI
Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice.
Angel Lanas,Luis A García-Rodríguez,Mónica Polo-Tomás,Marta Ponce,Inmaculada Alonso-Abreu,Maria Ángeles Pérez-Aisa,Javier Perez-Gisbert,Luis Bujanda,Manuel J. Castro,María Jesús Muñoz,Luis Rodrigo,Xavier Calvet,Dolores Del-Pino,Santiago García +13 more
TL;DR: Over the past decade, there has been a progressive change in the overall picture of GI events leading to hospitalization, with a clear decreasing trend in upper GI events and a significant increase in lower GI events, causing the rates of these two GI complications to converge.
Journal ArticleDOI
Management of Nonvariceal Upper Gastrointestinal Bleeding: Guideline Recommendations From the International Consensus Group.
Alan N. Barkun,Majid A Almadi,Ernst J. Kuipers,Loren Laine,Joseph J.Y. Sung,Frances Tse,Grigorios I. Leontiadis,Neena S. Abraham,Xavier Calvet,Francis K.L. Chan,James D. Douketis,Robert Enns,Ian M. Gralnek,Vipul Jairath,Dennis M. Jensen,James Y.W. Lau,Gregory Y.H. Lip,Romaric Loffroy,Fauze Maluf-Filho,Andrew C. Meltzer,Nageshwar D. Reddy,John R. Saltzman,John Marshall,Marc Bardou +23 more
TL;DR: This update focuses on resuscitation and risk assessment; preendoscopic, endoscopic, and pharmacologic management; and secondary prophylaxis for recurrent UGIB, as well as assessing the methodological quality of existing systematic reviews.
Journal ArticleDOI
Addition of a second endoscopic treatment following epinephrine injection improves outcome in high-risk bleeding ulcers.
TL;DR: Additional endoscopic treatment after epinephrine injection reduces further bleeding, need for surgery, and mortality in patients with bleeding peptic ulcer and when no scheduled follow-up endoscopies were performed.
Journal ArticleDOI
A meta‐analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection
TL;DR: Although triple therapies with a proton pump inhibitor, clarithromycin and either amoxycillin or metronidazole are the most widely accepted treatment for Helicobacter pylori infection, there is no consensus on how long treatment should be maintained for.